2023
DOI: 10.1016/j.cmi.2023.04.003
|View full text |Cite
|
Sign up to set email alerts
|

Which trial do we need? Bundle including antibiotic monitoring, rapid antibiotic susceptibility testing and molecular biology in septic shock

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 22 publications
0
1
0
Order By: Relevance
“…The appropriate timing for antibiotic administration in patients without shock with possible infection/sepsis is still object of discussion, particularly in critically ill patients with pre-existing organ dysfunction. Recently, a trial protocol including most of the main components of ASPs in ICU was proposed underlying the need for testing ASPs components as a unique intervention [74]. Indeed, patients with septic shock in early phase would be randomized in a cluster randomized, multicenter, trial to a personalized management strategy including rapid microbiological identification with adaptation of antibiotic dosages according to the daily TDM based on real MIC of the identified isolates versus standard care.…”
Section: Insights For Future Researchmentioning
confidence: 99%
“…The appropriate timing for antibiotic administration in patients without shock with possible infection/sepsis is still object of discussion, particularly in critically ill patients with pre-existing organ dysfunction. Recently, a trial protocol including most of the main components of ASPs in ICU was proposed underlying the need for testing ASPs components as a unique intervention [74]. Indeed, patients with septic shock in early phase would be randomized in a cluster randomized, multicenter, trial to a personalized management strategy including rapid microbiological identification with adaptation of antibiotic dosages according to the daily TDM based on real MIC of the identified isolates versus standard care.…”
Section: Insights For Future Researchmentioning
confidence: 99%